J. D. Baumgartner
- Immunology top 2%
- Epidemiology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Pharmacology top 5%
- Co-authors
- M. P. GlauserGláucia ZanettiDidier HeumannJ. CohenC BarrasGeorges E. GrauThierry CalandraPhilippe Gallay
- Topics
- Immune Response and Inflammation (16 papers)Sepsis Diagnosis and Treatment (7 papers)Antibiotic Resistance in Bacteria (6 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
J. D. Baumgartner
34 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Immunology 1.3k
- Epidemiology 905
- Molecular Biology 424
- Pulmonary and Respiratory Medicine 280
- Pharmacology 261
Countries citing papers authored by J. D. Baumgartner
This map shows the geographic impact of J. D. Baumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D. Baumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D. Baumgartner more than expected).
Fields of papers citing papers by J. D. Baumgartner
This network shows the impact of papers produced by J. D. Baumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D. Baumgartner. The network helps show where J. D. Baumgartner may publish in the future.
Co-authorship network of co-authors of J. D. Baumgartner
This figure shows the co-authorship network connecting the top 25 collaborators of J. D. Baumgartner. A scholar is included among the top collaborators of J. D. Baumgartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D. Baumgartner. J. D. Baumgartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | Sepsis and septic shock. | 17 |
| 4 | 0 | |
| 5 | 92 | |
| 6 | Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients. | 18 |
| 7 | 88 | |
| 8 | 58 | |
| 9 | 99 | |
| 10 | Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group. | 60 |
| 11 | 200 | |
| 12 | 40 | |
| 13 | 42 | |
| 14 | 19 | |
| 15 | Septic shock: pathogenesisbreakdown → | 593 |
| 16 | 122 | |
| 17 | Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shockbreakdown → | 428 |
| 18 | 32 | |
| 19 | 34 | |
| 20 | [HLA-B27 antigen and alkaptonuria]. | 1 |
About J. D. Baumgartner
J. D. Baumgartner is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 35 papers that have together received 2.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (16 papers), Sepsis Diagnosis and Treatment (7 papers) and Antibiotic Resistance in Bacteria (6 papers). The work is most often cited by research in Immunology (1.3k citations), Critical Care and Intensive Care Medicine (256 citations) and Applied Microbiology and Biotechnology (76 citations). J. D. Baumgartner has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include M. P. Glauser, Gláucia Zanetti, Didier Heumann, J. Cohen, M. P. Glauser, C Barras, M. P. Glauser, Georges E. Grau, Thierry Calandra and Philippe Gallay. Their work appears in journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.